These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18618613)
41. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells. Romano G Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350 [TBL] [Abstract][Full Text] [Related]
42. The use of stem cells in kidney disease. Chhabra P; Brayman KL Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150 [TBL] [Abstract][Full Text] [Related]
43. The economic value of investing in regenerative medicine. Hussain A; Rivers PA J Health Care Finance; 2009; 36(2):45-54. PubMed ID: 20499720 [TBL] [Abstract][Full Text] [Related]
44. Stem cell therapy to reduce radiation-induced normal tissue damage. Coppes RP; van der Goot A; Lombaert IM Semin Radiat Oncol; 2009 Apr; 19(2):112-21. PubMed ID: 19249649 [TBL] [Abstract][Full Text] [Related]
46. Stem and progenitor cell therapies: insights from non-human primate models. Dunbar CE Cytotherapy; 2004; 6(6):586-8. PubMed ID: 15764024 [TBL] [Abstract][Full Text] [Related]
47. Modeling epilepsy with pluripotent human cells. Muotri AR Epilepsy Behav; 2009 Jan; 14 Suppl 1():81-5. PubMed ID: 18845273 [TBL] [Abstract][Full Text] [Related]
48. Canine embryo-derived stem cells and models for human diseases. Schneider MR; Wolf E; Braun J; Kolb HJ; Adler H Hum Mol Genet; 2008 Apr; 17(R1):R42-7. PubMed ID: 18632696 [TBL] [Abstract][Full Text] [Related]
49. Cell therapy for cardiac disease: where do we go from here? Adler ED; Maddox TM Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):2-3. PubMed ID: 17180138 [No Abstract] [Full Text] [Related]
50. Regulation of 'stemness' and stem cell differentiation by microRNAs. Sartipy P; Olsson B; Hyllner J; Synnergren J IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883 [TBL] [Abstract][Full Text] [Related]
51. Commercial development of cell-based therapeutics: strategic considerations along the drug to tissue spectrum. Parenteau NL Regen Med; 2009 Jul; 4(4):601-11. PubMed ID: 19580408 [TBL] [Abstract][Full Text] [Related]
52. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. Freund C; Mummery CL J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339 [TBL] [Abstract][Full Text] [Related]
53. A dive into the stem cells world. Fagoonee S; Pellicano R; Altruda F Panminerva Med; 2009 Mar; 51(1):1-3. PubMed ID: 19352304 [No Abstract] [Full Text] [Related]
55. Disease models from pluripotent stem cells. Lengerke C; Daley GQ Ann N Y Acad Sci; 2009 Sep; 1176():191-6. PubMed ID: 19796247 [TBL] [Abstract][Full Text] [Related]
56. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Amabile G; Meissner A Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546 [TBL] [Abstract][Full Text] [Related]
57. The potential of stem cells. Pfendler KC; Kawase E Obstet Gynecol Surv; 2003 Mar; 58(3):197-208. PubMed ID: 12612460 [TBL] [Abstract][Full Text] [Related]
58. Using adult stem cells to treat heart failure--fact or fiction? Zimmet H; Krum H Heart Lung Circ; 2008; 17 Suppl 4():S48-54. PubMed ID: 19022705 [TBL] [Abstract][Full Text] [Related]
59. [Adult stem cells and regenerative medicine: progress and prospect in some main fields]. Fu XB Zhonghua Yi Xue Za Zhi; 2007 May; 87(17):1153-5. PubMed ID: 17686229 [No Abstract] [Full Text] [Related]
60. Advances and challenges in the therapeutic use of stem cells. Hamilton CG Nurs Times; 2005 Nov 8-14; 101(45):21-3. PubMed ID: 16312076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]